Ameriprise Financial Inc Eagle Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.63 - $15.21 $1.07 Million - $3.52 Million	-231,611 Reduced 89.95%	25,869 $135,000
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $135,931 - $204,478	-8,937 Reduced 3.35%	257,480 $4.06 Million
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $1.22 Million - $2.19 Million	68,609 Added 34.68%	266,417 $5.18 Million
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $138,256 - $188,074	-5,517 Reduced 2.71%	197,808 $5.61 Million
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $202,737 - $322,773	-8,116 Reduced 3.84%	203,325 $5.94 Million
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $1.1 Million - $1.95 Million	-41,460 Reduced 16.39%	211,441 $5.59 Million
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $487,734 - $607,008	-11,821 Reduced 4.47%	252,901 $11.2 Million
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $104,049 - $122,768	-2,334 Reduced 0.87%	264,722 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $4.98 Million - $6.18 Million	108,600 Added 68.54%	267,056 $13.6 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $335,081 - $426,828	7,652 Added 5.07%	158,456 $8.84 Million
Q2 2021 Aug 16, 2021	BUY	$36.86 - $44.5 $1.11 Million - $1.34 Million	30,104 Added 24.94%	150,804 $6.46 Million
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $466,623 - $589,875	11,573 Added 10.61%	120,700 $5.04 Million
Q4 2020 Feb 12, 2021	BUY	$41.72 - $51.34 $122,448 - $150,682	2,935 Added 2.76%	109,127 $5.08 Million
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $757,799 - $1.05 Million	20,470 Added 23.88%	106,192 $4.51 Million
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $3,070 - $3,906	-71 Reduced 0.08%	85,722 $4.11 Million
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $7,389 - $12,915	-215 Reduced 0.25%	85,793 $3.95 Million
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $67,628 - $80,065	-1,245 Reduced 1.43%	86,008 $5.17 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $413,220 - $465,444	-7,760 Reduced 8.17%	87,253 $4.94 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $1.71 Million - $2.15 Million	36,760 Added 63.1%	95,013 $5.29 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $177,140 - $237,439	-4,582 Reduced 7.29%	58,253 $2.94 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $36,903 - $68,068	-1,005 Reduced 1.57%	62,835 $2.53 Million
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $1.12 Million - $1.41 Million	16,840 Added 35.83%	63,840 $4.43 Million
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $4.01 Million - $6 Million	-78,284 Reduced 62.49%	47,000 $3.56 Million
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $47,465 - $60,842	910 Added 0.73%	125,284 $6.6 Million
Q4 2017 Feb 12, 2018	SELL	$49.6 - $60.87 $706,552 - $867,093	-14,245 Reduced 10.28%	124,374 $6.64 Million
Q3 2017 Nov 07, 2017	BUY	$46.62 - $60.36 $6.46 Million - $8.37 Million	138,619	138,619 $8.27 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account